• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Neuland Laboratories Ltd

+ Add to Watchlist

NLL:IN

434.65 INR 7.05 1.65%

As of 06:06:15 ET on 11/28/2014.

Snapshot for Neuland Laboratories Ltd (NLL)

Open: 423.65 Day's Range: 420.15 - 436.00 Volume: 13,647
Previous Close: 427.60 52wk Range: 230.43 - 529.75 1-Yr Rtn: +67.99%

Stock Chart for NLL

No chart data available.
  • NLL:IN 434.65
  • 1D
  • 1M
  • 1Y
427.60
Interactive NLL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NLL

Current P/E Ratio (ttm) 12.9725
Estimated P/E(03/2015) 9.6589
Relative P/E vs. SENSEX 0.6610
Earnings Per Share (INR) (ttm) 33.5054
Est. EPS (INR) (03/2015) 45.0000
Est. PEG Ratio -
Market Cap (M INR) 3,859.89
Shares Outstanding (M) 8.88
30 Day Average Volume 25,557
Price/Book (mrq) 2.8462
Price/Sale (ttm) 0.7468
Dividend Indicated Gross Yield 0.33%
Cash Dividend (INR) 1.4335
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 0.64%
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NLL

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for NLL

Neuland Laboratories Limited is a pharmaceutical company, which specializes in bulk drugs and intermediates.

Davuluri Rama Mohan RaoChairman/Managing DirectorDavuluri Sucheth RaoCEO/Executive Director
N S ViswanathanChief Financial OfficerDavuluri Saharsh RaoPres:Contract Research/Executive Dir
More Company Profile & Key Executives for NLL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil